Role and prognostic significance of the Ki‐67 index in non‐Hodgkin's lymphoma
暂无分享,去创建一个
Ofer Shpilberg | O. Bairey | O. Shpilberg | Adi Broyde | Olga Boycov | Yulia Strenov | Elimelech Okon | Osnat Bairey | E. Okon | Y. Strenov | A. Broyde | O. Boycov
[1] L. Gordon,et al. Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas. , 1996, Blood.
[2] J. Gerdes,et al. The Ki-67 protein: fascinating forms and an unknown function. , 2000, Experimental cell research.
[3] T. Lister,et al. The prognostic value of Ki67 immunostaining in non‐Hodgkin's lymphoma , 1988, The Journal of pathology.
[4] Johannes Gerdes,et al. The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.
[5] J. Krueger,et al. Classification of Non-Hodgkin's Lymphoma: A Proposal. , 1997, The oncologist.
[6] G Flandrin,et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] A. Rosenwald,et al. Burkitt lymphoma versus diffuse large B-cell lymphoma. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] T. Grogan,et al. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67 , 1988 .
[9] W. Chan,et al. Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. , 1995, Blood.
[10] D Schmidt,et al. Prognostic significance of the proliferative activity in neuroblastoma. , 1997, The American journal of pathology.
[11] Andrew Lister,et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Emili Montserrat,et al. A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.
[13] G. Palestro,et al. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. , 1994, Journal of clinical pathology.
[14] C. Dunphy,et al. Grading of follicular lymphoma: comparison of routine histology with immunohistochemistry. , 2007, Archives of pathology & laboratory medicine.
[15] K. Gatter,et al. Ki67 protein: the immaculate deception? , 2002, Histopathology.
[16] F. Schmitt,et al. Proliferating Cell Nuclear Antigen (Pcna) In Non‐Hodgkin'S Lymphomas: Correlation with Working Formulation and Kiel classification in formalin‐fixed paraffin‐embedded material , 1996, Pathology.
[17] G. Pruneri,et al. Cyclin D3 immunoreactivity in follicular lymphoma is independent of the t(6;14)(p21.1;q32.3) translocation or cyclin D3 gene amplification and is correlated with histologic grade and Ki‐67 labeling index , 2004, International journal of cancer.
[18] S. Pileri,et al. PROGNOSTIC RELEVANCE OF TUMOUR-CELL GROWTH FRACTION IN MALIGNANT NON-HODGKIN'S LYMPHOMAS , 1987, The Lancet.
[19] J. Overgaard,et al. Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantly , 1999, Prostate Cancer and Prostatic Diseases.
[20] A. Cnaan,et al. Proliferation markers in breast carcinoma. , 1996, American journal of clinical pathology.
[21] Ellen,et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. , 1994, Blood.
[22] S. Kvaløy,et al. Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma—a Nordic Lymphoma Group study , 2004, Annals of Hematology.
[23] N. Harris,et al. Low Histologic Grade Follicular Lymphoma With High Proliferation Index: Morphologic and Clinical Features , 2005, The American journal of surgical pathology.
[24] Nicola Pimpinelli,et al. WHO-EORTC classification for cutaneous lymphomas. , 2005, Blood.
[25] C. Cordon-Cardo,et al. Ki‐67 detected by MIB‐1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma , 1998, Cancer.